Catalyst Event
Medtronic PLC (MDT) · Other
From Akros SCHK HK-Global Brain-Computer Interface Index (ASHGBCI)
3/23/2026, 12:00:00 AM
On March 23, 2026, Medtronic announced it received expanded U.S. FDA approval for its OmniaSecure defibrillation lead for placement in the left bundle branch area, enabling its use for conduction system pacing. (Estimated 1-2% impact due to expanded product indication).
Korean Translation
2026년 3월 23일, 메드트로닉은 자사의 옴니아시큐어(OmniaSecure) 제세동기 리드가 심장 좌각 영역에 삽입하여 전도 시스템 페이싱에 사용할 수 있도록 미국 FDA의 확대 승인을 받았다고 발표함. (제품 적응증 확대로 인해 1-2%의 주가 영향이 예상됨).
Related Recent Events
Eli Lilly and Co (LLY) · Earnings Release
First quarter 2026 earnings release and conference call, which is estimated to have a >=10% price impact, is scheduled.
4/30/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Earnings Release
Abbott's first-quarter 2026 financial results announcement and conference call on April 16, 2026, for which market analysts estimate a >=5% price impact, are scheduled.
4/16/2026, 12:00:00 AM
Johnson & Johnson (JNJ) · Earnings Release
Johnson & Johnson's Q1 2026 earnings release is scheduled for April 14, 2026, before the market opens scheduled.
4/14/2026, 12:00:00 AM
Eli Lilly and Co (LLY) · Other
U.S. Food and Drug Administration (FDA) decision on orforglipron, an oral weight-loss pill, is expected. The target action date was previously extended, and a >=10% price impact is expected.
4/10/2026, 12:00:00 AM
Oracle Corp (ORCL) · Other
Veritone announced on March 26, 2026, a multi-year agreement to migrate its AI solutions to Oracle Cloud Infrastructure (OCI), signaling a strategic customer win for Oracle's cloud business.
3/26/2026, 12:00:00 AM
Abbott Laboratories (ABT) · Other
S&P Global Ratings is expected to downgrade Abbott's credit rating to 'A+' from 'AA-' on March 24, 2026, following the Exact Sciences acquisition; market analysts estimate a >=10% price impact.
3/24/2026, 12:00:00 AM